Internal Medicine, Hematology & Oncology · Minneapolis, MN
NPI
1407058076
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
7
Medicare group memberships
Hospitals
2
Hospital affiliations
500 Harvard St SE
Minneapolis, MN, 55455
Phone (612) 273-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$24K
396 services
Medicare patients, 2024
80
Average age 58
Drug cost, 2024
$1.4M
335 prescriptions
Company payments, 2025
$57.2
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Roy L Kao was code 99233 (hospital e&m - subsequent), 90 times for 22 patients. In total Roy L Kao billed 396 services in 35 codes, and Medicare paid $24K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 90 | 22 | $88.30 | $7,947 |
| G0316 Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by th | Facility | 71 | 12 | $22.92 | $1,627 |
| 99215 Office E&M - Established | Facility | 51 | 26 | $104.40 | $5,324 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 48 | 16 | $22.54 | $1,082 |
| 99223 Hospital E&M - Initial | Facility | 16 | 15 | $121.33 | $1,941 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 14 | 11 | $12.53 | $175 |
| 99205 Office E&M - New | Facility | 11 | 11 | $136.25 | $1,499 |
By year: 2022 $5,423 for 56 services; 2023 $28K for 457 services; 2024 $24K for 396 services.
Medicare prescription drug claims, 2024
In 2024, the drug Roy L Kao prescribed most often to Medicare patients was Acyclovir, with 35 prescriptions and refills. In total Roy L Kao wrote 335 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 35 | 37 | Under 11 | $621 |
| Hydroxyurea Generic | 27 | 43 | Under 11 | $559 |
| Morphine Sulfate Er Morphine Sulfate | 18 | 18 | Under 11 | $179 |
| Oxycodone Hcl Generic | 16 | 16 | Under 11 | $75.79 |
| Hydrocortisone Generic | 14 | 14 | Under 11 | $582 |
| Omeprazole Generic | 13 | 13 | Under 11 | $112 |
| Ojjaara Momelotinib Dihydrochloride | 12 | 12 | Under 11 | $343K |
| Jakafi Ruxolitinib Phosphate | 12 | 12 | Under 11 | $209K |
| Xarelto Rivaroxaban | 11 | 11 | Under 11 | $6,783 |
| Amlodipine Besylate Generic | 11 | 11 | Under 11 | $69.47 |
| Rydapt Midostaurin | 11 | 11 | Under 11 | $238K |
| Zolpidem Tartrate Generic | 11 | 11 | Under 11 | $64.13 |
Brand drugs: 98 claims; generic drugs: 237 claims; opioid claims: 41.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Roy L Kao $57.2 ($57.2 in general payments such as food, travel and fees) from 2 companies. The largest payer was Vertex Pharmaceuticals Incorporated with $57.2.
| Company | Payments | Amount |
|---|---|---|
| Vertex Pharmaceuticals Incorporated VRTX | 1 | $57.2 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.